Additionally, there is no specific carrier of GSH at the cell membrane level
Ongoing assessment Dose adjustments, substitutions, and/or addition of other antihyperglycemic medications should be made in order to reach the target A1C within 3 to 6 months [Grade D, Consensus]
Adverse glycaemic effects of cancer therapy: indications for a rational approach to cancer patients with diabetes
Women taking oral contraceptives may show decreased cobalamin levels because of a decrease in cobalamin carrier protein, however, this may not result in a deficiency
Benefits of Mycotoxin Testing Accurate Diagnosis: Mycotoxin testing provides a direct measure of mold toxin burden in the body, leading to a more accurate diagnosis
No clinically relevant difference in the pharmacokinetics of TRESIBA was identified in a study comparing healthy subjects and subjects with kidney impairment including subjects with end stage kidney disease [see Clinical Pharmacology (12.3)]